
Producers of Medium-Low Value Consumables and High-Value Medical Devices

High-Tech Interventional Medical Product R&D, Production, and Sales Company

Pioneer in Medical Device Media Coverage
Sharing Professional Medical Device Knowledge
On July 8, 2026, the 2025 National Science and Technology Awards were officially announced. Shandong JW Medical Systems Ltd., a subsidiary of Bluesail Medical’s Cardiovascular and Cerebrovascular Division, as a key participating entity, was honored with the Second Prize of the National Science and Technology Progress Award for its significant contributions to the award-winning achievement.

Enterprise Name | Project Name |
Jw Medical Systems Limted | Innovation and Clinical Application of Interventional Diagnostic and Therapeutic Devices for Vascular Occlusive Diseases |
The National Science and Technology Award is the highest national honor in China’s science and technology sector. This award marks another national-level recognition of JWMS’s innovative achievements, following its participation in a project that received the Second Prize of the National Technological Invention Award in 2011.This award serves as a high recognition of JWMS’s long-term dedication to cardiovascular interventional devices, its advancement in the engineering and clinical translation of original technologies, and its significant achievements in continuously building a full-chain solution for cerebrovascular and cardiovascular interventions. It fully demonstrates the company’s strong capability in overcoming key technical challenges and meeting clinical needs in the field of high-end medical devices.
Unceasing Innovation, Moving Toward the New.JWMS will continue to adhere to a clinical value-oriented approach, deepen collaborative innovation among industry, academia, research, and healthcare institutions, accelerate the translation of innovative achievements into global applications, and serve patients with higher-quality Chinese medical device solutions.